Letters to the Editor
Second ear stapedectomy From Mr R P E Barton, Consultant ENT Surgeon Leicester Royal Infirmary, Leicester LE15WW Dear Sir, With reference to the paper by Sergeant & Wadsworth (July Journal, p 505), it would seem to me that logic is lacking in one part of the traditional teaching on second side stapedectomy.
Take the case of a new patient with otosclerosis and a bilateral conductive hearing loss. A trainee otologist operates on one ear and the patient gets a 'dead' ear. That patient is then condemned to a hearing aid in the remaining ear for the rest of his life with no hope of salvage surgery. Take a second patient who has a good result following a stapedectomy in one ear, with a conductive deafness in the other ear and who is requesting a second side stapedectomy. The experienced otologist operates and, unfortunately, also produces a 'dead' ear. The patient still has normal hearing in the previously operated side; he is therefore very little the worse off, despite the surgical disaster, and requires no hearing aid. Ergo, perhaps the patient presenting with bilateral otosclerosis should have his first stapedectomy performed by the experienced otologist, and the trainee should only be allowed to operate on a second ear where there has been a successful outcome on the first side? 
Book reviews
The Adrenal Gland. V H T James (ed) pp 332 $43.52 New York: Raven Press 1979 This is the third number in the so far generally splendid series 'Comprehensive Endocrinology', which aims to encompass human basic and clinically applied endocrinology. It is an excellent review and can be recommended as a concise set of essays on the major areas of interest related to the adrenal cortex and medulla. Particularly comprehensive and clearly written presentations on the histological aspects of normal and pathological adrenal glands (Neville and O'Hare), adrenocortical insufficiency (Irvine, Toft and Feek) and excess (Jeffcoate and Edwards), and mineralocorticoid excess (Stockigt) are especially welcome. The chapters on the adrenal medulla, congenital Hypokalaemic thyrotoxic periodic paralysis From Dr C P Petch King's Lynn, Norfolk PE316HA Dear Sir, Dr Papouchado's case of hypokalaemic thyrotoxic periodic paralysis (July Journal, p 519) is of much interest but it is not, as he claims, the first in a Caucasian Briton. In 1964 I reported this condition in a British engineer of 32 (Lancet 1964, ii, 366) . My problem was easier in that thyrotoxicosis was clinically obvious, and the paralysis could be reproduced by hypokalaemia induced by oral glucose. He responded promptly to methyl thiouracil, but eighteen months' follow up showed that permanent remission had not been obtained and the paralytic symptoms recurred with thyrotoxic relapse. Subtotal thyroidectomy achieved a cure.
No one has ever been able to explain to me why this complication ofa common disease, so frequent in Japan, is so rare in Western Europe.
CP PBTCH
9 August 1980 adrenal hyperplasia and radionuclide imaging in adrenal disease are useful but suffer intheir impact from the relative lack of recent, really novel developments of clinical or physiological significance. Biosynthesis and metabolism of adrenocortical steriods are necessarily and well covered (Brooks), and the difficult and usually unsatisfactory topic of adrenal androgens is dealt with by Vermeulen and Rubens. The section on the control of adrenocortical hormones and ACTH secretion is least satisfactory, largely because it is often difficult to distinguish data obtained only in animals from those for which evidence exists in man. We would perhaps like to have seen more in this section on the control and nature of the synthesis, processing and secretion of the
